Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Transcenta to Hold 3 Exchange Sessions on Post-SITC Business Update Call & TST003 data release and pipeline development progress update 2022-11-09 21:09
Axiomtek launches the newest medical grade artificial intelligence computing system - mBOX100 2022-11-09 17:21
JW Therapeutics Announces its Cell Immunotherapy Drugs Have Successfully Benefited 300 Patients 2022-11-09 17:00
Siemens Healthineers to demonstrate the remote capabilities of Corindus CorPath GRX Robotic System using Mentice VIST ® Simulator 2022-11-09 16:52
TES Pharma Congratulates Intercept Pharmaceuticals on their Presentation of Phase 1 INT-787 Data at the AASLD Meeting and the Initiation of the Phase 2a FRESH Study in Patients with Severe Alcohol-Associated Hepatitis 2022-11-09 06:00
Himalaya Therapeutics Announces Highlights of Recent Clinical Progress 2022-11-08 23:08
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion 2022-11-08 22:00
XJTLU and University of Liverpool to inaugurate Joint Centre for Pharmacology and Therapeutics 2022-11-08 21:25
Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax Prototype Vaccine as a Booster 2022-11-08 21:00
Traditional Chinese Medicine Lianhua Qingwen Attracted Eyes in the Annual National Conference of Pharmaceutical Society of Nigeria 2022-11-08 20:25
BIORCHESTRA announces that BMD-001 reduces Amyloid-β and Tau in non-human primate animal model of Alzheimer's Disease at the RNA Leaders USA Conference in Boston 2022-11-08 15:59
Ground-Breaking SIRIUS Endoscope System Is Leading the Next Minimally Invasive Surgical Revolution 2022-11-08 15:53
BIORCHESTRA announces that BMD-001 reduces Amyloid-β and Tau in non-human primate animal model of Alzheimer's Disease at the RNA Leaders USA Conference in Boston 2022-11-08 15:30
Update on overseas clinical trials progress of novel adjuvant COVID-19 vaccine ReCOV 2022-11-08 15:17
111 to Announce Third Quarter 2022 Unaudited Financial Results on December 1, 2022 - Conference Call to Follow 2022-11-08 14:09
Sirnaomics Doses the First Patient in Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Aesthetics Treatment 2022-11-08 05:13
Alterity Therapeutics Announces Presentation of Data from the bioMUSE Natural History Study at the American Autonomic Society Annual Meeting 2022-11-07 23:25
Lunit Highlights the Effectiveness of AI in Acceleration of Immunotherapy Research--Findings to be Presented at SITC 2022 2022-11-07 21:00
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris, Completed the First Patient Dose in Phase III Trial 2022-11-07 10:04
Ascletis Announces Poster Presentation of Phase I, Single-Dose Study of ASC43F for NASH at AASLD Annual Meeting 2022 2022-11-07 08:10
1 103 104 105 106 107 376